Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2010-11-08
2011-10-04
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S355000
Reexamination Certificate
active
08030308
ABSTRACT:
The invention is concerned with novel heterobicyclic derivatives of formula (I)wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
REFERENCES:
patent: 122109 (1984-10-01), None
patent: 1 243 583 (2002-09-01), None
patent: 2006/131452 (2006-12-01), None
Jackson et al., 1999, Biochem. J. 341, 483-489.
Jackson et al., 2000, J. Biol. Chem. 275, 19560-19566.
J. Am. Chem. Soc. 1983, 105, 5015.
Broadway, N.M., et al., FEBS Letters, vol. 371, pp. 137-139 (1995), XP-002398463.
Ackermann Jean
Bleicher Konrad
Ceccarelli Simona M.
Chomienne Odile
Mattei Patrizio
Habte Kahsay T
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287260